Laura Defraia, CNP
Women's Health Nurse Practitioner in Grand Rapids, Michigan. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,452 in Women's Health Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Laura Defraia, CNP reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 479 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 479
- Part D claims, 2023
- 91%
- generic prescribing
- $58.61
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Laura Defraia, CNP's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Laura Defraia, CNP sits
This provider among women's health nurse practitioner peers
Across the 802 women's health nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Laura Defraia, CNP writes more Part D claims than 87% of them and scores higher on MIPS quality than 95% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one women's health nurse practitioner peer from a representative sample of 60; the gold marker is Laura Defraia, CNP. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Laura Defraia, CNP?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Women's Health Nurse Practitioner compares to other specialties among Michigan providers
Largest specialties in Michigan (% of in-state providers)
Women's Health Nurse Practitioner ranks #112 among Michigan's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Michigan provider total, by primary NUCC taxonomy. The highlighted bar is Women's Health Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Laura Defraia, CNP's 2023 MIPS final score plotted against the Women's Health Nurse Practitioner national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Women's Health Nurse Practitioner) - 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Women's Health Nurse Practitioner US NPIs
100/100 MIPS final score - 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Women's Health Nurse Practitioner. Quality dim: 87.5.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Laura Defraia, CNP appears in the CMS NPPES registry as a Women's Health Nurse Practitioner provider holding CNP credentials at 4069 LAKE DR SE STE 118, Grand Rapids, MI, 49546, with a listed phone of (616) 267-8520. NPI 1194092957 was issued on 11/22/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Defraia most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 479 prescription claims written by this provider, covering 126 Medicare beneficiaries and totaling roughly $59K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 87.5), compared with the national average of 83.1.
Women's Health Nurse Practitioner is a mid-sized specialty nationwide, with 9,452 enrolled providers across 55 states and an average of 262 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194092957 |
|---|---|
| Specialty | Women's Health Nurse Practitioner |
| Credentials | CNP |
| Gender | Female |
| NPI Issued | 11/22/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Laura Defraia, CNP's current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Laura Defraia, CNP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Laura Defraia, CNP. Source: openpaymentsdata.cms.gov.
Total received
$59
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Laura Defraia, CNP. To verify Laura Defraia, CNP's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 479 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,294
- Total Day Supply
- 37,779
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $12K
- Generic Drug Cost
- $47K
Patient Demographics
- Average Patient Age
- 67.5 years
- Avg HCC Risk Score
- 0.78
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 29, 65-74: 71, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Laura Defraia, CNP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Estradiol
Estradiol
114 claims
- Estradiol (Twice W…
Estradiol (Twice Weekly)
94 claims
- Dotti 42
Dotti
42 claims
- Clobetasol Propion… 23
Clobetasol Propionate
23 claims
- Norethindrone Acet… 18
Norethindrone Acetate
18 claims
- Escitalopram Oxalate 17
Escitalopram Oxalate
17 claims
- Liothyronine Sodium 16
Liothyronine Sodium
16 claims
- Estradiol-Norethin… 11
Estradiol-Norethindrone Acetat
11 claims
| Drug | Claims |
|---|---|
| Estradiol | 114 |
| Estradiol (Twice Weekly) Estradiol | 94 |
| Dotti Estradiol | 42 |
| Clobetasol Propionate | 23 |
| Norethindrone Acetate | 18 |
| Escitalopram Oxalate | 17 |
| Liothyronine Sodium | 16 |
| Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet | 11 |
| Progesterone "Progesterone | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Women's Health Nurse Practitioner Overview
How Laura Defraia, CNP fits within the Women's Health Nurse Practitioner landscape nationally.
Laura Defraia, CNP's 479 claims are above the specialty average of 262.
Nearby Women's Health Nurse Practitioner Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Defraia.
Compare Women's Health Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Women's Health Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Michigan
Frequently Asked Questions
What is Laura Defraia, CNP's specialty? ▼
How much does Laura Defraia, CNP prescribe under Medicare Part D? ▼
What is Laura Defraia, CNP's Medicare quality score? ▼
Where is Laura Defraia, CNP located? ▼
What is Laura Defraia, CNP's NPI number? ▼
Does Laura Defraia, CNP prescribe more brand-name or generic drugs? ▼
How many Women's Health Nurse Practitioner providers are there in the US? ▼
What drugs does Laura Defraia, CNP prescribe most often? ▼
Does Laura Defraia, CNP accept Medicare? ▼
How can I verify Laura Defraia, CNP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology